Nasalferon, a medicine developed by Cuba's Center for Genetic Engineering and Biotechnology (CIGB) and currently used to treat Covid-19 could be used against different acute respiratory conditions, an authorized source reported»
The CIGB-Mariel Biotechnological Industrial Complex is taking on the production of its own anti-Covid vaccines, one more step Cuba is taking today to continue advancing towards the prequalification of its immunogens by the World Health Organization (WHO).»
Next Wednesday, April 14th, Cuba and Germany will discuss new areas for cooperation»
The Center for Genetic Engineering and Biotechnology and the Biotechnology and Pharmaceutical Industry Enterprise has been approved as the first Cuban High Technology Enterprises»
This genocidal policy imposed by the White House on Cuba limits access to raw materials, technologies and equipment necessary for the development of this sector»
This is the first scientific result in which the Center for Genetic Engineering and Biotechnology (CIGB) is involved, which obtains an intellectual property and has been already patented in Cuba and other countries, including some First World nations»
The world’s first skin cancer treatment, which targets basal cell carcinoma, has appeared in pharmacies across Cuba within only six months of its entry into the market»
Specialists of the Center of Genetic Engineering and Biotechnology (CIGB) has created a new drug called Heberferon, aimed at reducing or eliminating non-melanoma skin tumors»
Escambray ENGLISH EDITION